{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:11:27Z","timestamp":1769026287587,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41409-025-02734-8","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T16:59:54Z","timestamp":1761670794000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of outcomes of BuCy versus BuCyMel as preparation for allogeneic HSCT in infants with acute myeloid leukemia in first complete remission: a multicenter study from the EBMT PDWP"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6798-8998","authenticated-orcid":false,"given":"Andre Manfred","family":"Willasch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6865-8509","authenticated-orcid":false,"given":"Claire","family":"Horgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-8515","authenticated-orcid":false,"given":"Christina","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5879-0610","authenticated-orcid":false,"given":"Adriana","family":"Balduzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Hugues","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-1744","authenticated-orcid":false,"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8732-5611","authenticated-orcid":false,"given":"Ali","family":"Al-Ahmari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3654","authenticated-orcid":false,"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile","family":"Renard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oana","family":"Mirci-Danicar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Jubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-501X","authenticated-orcid":false,"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evgenios","family":"Gossetis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-5709","authenticated-orcid":false,"given":"G\u00e9rard","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9257-900X","authenticated-orcid":false,"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Formankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchan","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4610-0870","authenticated-orcid":false,"given":"Alessandra","family":"Biffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3136-6270","authenticated-orcid":false,"given":"Fanny","family":"Rialland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos","family":"Toren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Dalissier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"Corbacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1447-7286","authenticated-orcid":false,"given":"Katharina","family":"Kleinschmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7810-6900","authenticated-orcid":false,"given":"Maud","family":"Ngoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9102-4427","authenticated-orcid":false,"given":"Jacques-Emmanuel","family":"Galimard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1174-5799","authenticated-orcid":false,"given":"Krzysztof","family":"Kalwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"2734_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41375-019-0584-8","volume":"34","author":"MG Sauer","year":"2020","unstructured":"Sauer MG, Lang PJ, Albert MH, Bader P, Creutzig U, Eyrich M, et al. Hematopoietic stem cell transplantation for children with acute myeloid leukemia-results of the AML SCT-BFM 2007 trial. Leukemia. 2020;34:613\u201324. https:\/\/doi.org\/10.1038\/s41375-019-0584-8.","journal-title":"Leukemia"},{"key":"2734_CR2","doi-asserted-by":"publisher","unstructured":"Versluys AB, Boelens JJ, Pronk C, Lankester A, Bordon V, Buchner J, et al. Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens. Bone Marrow Transplant. 2021. https:\/\/doi.org\/10.1038\/s41409-020-01201-w","DOI":"10.1038\/s41409-020-01201-w"},{"key":"2734_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/bjh.14720","volume":"178","author":"L Karlsson","year":"2017","unstructured":"Karlsson L, Forestier E, Hasle H, Jahnukainen K, Jonsson OG, Lausen B, et al. Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia. Br J Haematol. 2017;178:592\u2013602. https:\/\/doi.org\/10.1111\/bjh.14720.","journal-title":"Br J Haematol"},{"key":"2734_CR4","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1200\/JCO.2003.11.066","volume":"21","author":"N Aladjidi","year":"2003","unstructured":"Aladjidi N, Auvrignon A, Leblanc T, Perel Y, Benard A, Bordigoni P, et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89\/91 protocol of the French Society of Pediatric Hematology and Immunology. Journal Clin Oncol. 2003;21:4377\u201385. https:\/\/doi.org\/10.1200\/JCO.2003.11.066.","journal-title":"Journal Clin Oncol"},{"key":"2734_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s12185-014-1616-9","volume":"100","author":"H Nakayama","year":"2014","unstructured":"Nakayama H, Tabuchi K, Tawa A, Tsukimoto I, Tsuchida M, Morimoto A, et al. Outcome of children with relapsed acute myeloid leukemia following initial therapy under the AML99 protocol. Int J Hematol. 2014;100:171\u20139. https:\/\/doi.org\/10.1007\/s12185-014-1616-9.","journal-title":"Int J Hematol"},{"key":"2734_CR6","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1038\/leu.2010.127","volume":"24","author":"A Sander","year":"2010","unstructured":"Sander A, Zimmermann M, Dworzak M, Fleischhack G, von Neuhoff C, Reinhardt D, et al. Consequent and intensified relapse therapy improved survival in pediatric AML: results of relapse treatment in 379 patients of three consecutive AML-BFM trials. Leukemia. 2010;24:1422\u20138. https:\/\/doi.org\/10.1038\/leu.2010.127.","journal-title":"Leukemia"},{"key":"2734_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1365-2141.2006.06419.x","volume":"136","author":"J Abrahamsson","year":"2007","unstructured":"Abrahamsson J, Clausen N, Gustafsson G, Hovi L, Jonmundsson G, Zeller B, et al. Improved outcome after relapse in children with acute myeloid leukaemia. Br J Haematol. 2007;136:229\u201336. https:\/\/doi.org\/10.1111\/j.1365-2141.2006.06419.x.","journal-title":"Br J Haematol"},{"key":"2734_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/cncr.22385","volume":"109","author":"JE Rubnitz","year":"2007","unstructured":"Rubnitz JE, Razzouk BI, Lensing S, Pounds S, Pui CH, Ribeiro RC. Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia. Cancer. 2007;109:157\u201363. https:\/\/doi.org\/10.1002\/cncr.22385.","journal-title":"Cancer"},{"key":"2734_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/sj.leu.2401254","volume":"13","author":"DK Webb","year":"1999","unstructured":"Webb DK, Wheatley K, Harrison G, Stevens RF, Hann IM. Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party. Leukemia. 1999;13:25\u201331. https:\/\/doi.org\/10.1038\/sj.leu.2401254.","journal-title":"Leukemia"},{"key":"2734_CR10","doi-asserted-by":"publisher","unstructured":"Willasch AM, Peters C, Sedlacek P, Dalle JH, Kitra-Roussou V, Yesilipek A, et al. Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP study. Bone Marrow Transplant. 2020. https:\/\/doi.org\/10.1038\/s41409-020-0854-0","DOI":"10.1038\/s41409-020-0854-0"},{"key":"2734_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1200\/JCO.20.02529","volume":"39","author":"C Peters","year":"2021","unstructured":"Peters C, Dalle JH, Locatelli F, Poetschger U, Sedlacek P, Buechner J, et al. Total body irradiation or chemotherapy conditioning in childhood all: a multinational, randomized, noninferiority phase iii study. Journal Clin Oncol: Off J Am Soc Clin Oncol. 2021;39:295\u2013307. https:\/\/doi.org\/10.1200\/JCO.20.02529.","journal-title":"Journal Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"2734_CR12","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.1182\/blood-2013-07-514448","volume":"122","author":"EA Copelan","year":"2013","unstructured":"Copelan EA, Hamilton BK, Avalos B, Ahn KW, Bolwell BJ, Zhu X, et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 2013;122:3863\u201370. https:\/\/doi.org\/10.1182\/blood-2013-07-514448.","journal-title":"Blood"},{"key":"2734_CR13","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.bbmt.2015.08.011","volume":"21","author":"H Ishida","year":"2015","unstructured":"Ishida H, Kato M, Kudo K, Taga T, Tomizawa D, Miyamura T, et al. Comparison of outcomes for pediatric patients with acute myeloid leukemia in remission and undergoing allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens based on either intravenous busulfan or total body irradiation: a report from the Japanese Society for Hematopoietic Cell Transplantation. Biol Blood Marrow Transpl. 2015;21:2141\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2015.08.011.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2734_CR14","first-page":"844","volume":"8","author":"F Locatelli","year":"1994","unstructured":"Locatelli F, Pession A, Bonetti F, Maserati E, Prete L, Pedrazzoli P, et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia. 1994;8:844\u20139.","journal-title":"Leukemia"},{"key":"2734_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"2734_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1002\/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#","volume":"18","author":"PK Andersen","year":"1999","unstructured":"Andersen PK, Klein JP, Zhang MJ. Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests. Stat Med. 1999;18:1489\u20131500.","journal-title":"Stat Med"},{"key":"2734_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2020. https:\/\/www.R-project.org\/."},{"key":"2734_CR18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbmt.2016.11.022","volume":"23","author":"G Lucchini","year":"2017","unstructured":"Lucchini G, Labopin M, Beohou E, Dalissier A, Dalle JH, Cornish J, et al. Impact of conditioning regimen on outcomes for children with acute myeloid leukemia undergoing transplantation in first complete remission. An analysis on behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation. Biol Blood Marrow Transpl. 2017;23:467\u201374. https:\/\/doi.org\/10.1016\/j.bbmt.2016.11.022.","journal-title":"Biol Blood Marrow Transpl"},{"key":"2734_CR19","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/leu.2010.297","volume":"25","author":"B Strahm","year":"2011","unstructured":"Strahm B, N\u00f6llke P, Zecca M, Korthof ET, Bierings M, Furlan I, et al. EWOG-MDS study group. Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia. 2011;25:455\u201362. https:\/\/doi.org\/10.1038\/leu.2010.297.","journal-title":"Leukemia"},{"key":"2734_CR20","first-page":"489","volume":"18","author":"PA Carpenter","year":"1996","unstructured":"Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan. Bone Marrow Transpl. 1996;18:489\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"2734_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/bmt.2014.246","volume":"50","author":"F Locatelli","year":"2015","unstructured":"Locatelli F, Masetti R, Rondelli R, Zecca M, Fagioli F, Rovelli A, et al. Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AIEOP AML-2002\/01 study. Bone Marrow Transpl. 2015;50:181\u20138. https:\/\/doi.org\/10.1038\/bmt.2014.246.","journal-title":"Bone Marrow Transpl"},{"key":"2734_CR22","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/bmt.2012.204","volume":"48","author":"R Beier","year":"2013","unstructured":"Beier R, Albert MH, Bader P, Borkhardt A, Creutzig U, Eyrich M, et al. Allo-SCT using BU, CY and melphalan for children with AML in second CR. Bone Marrow Transpl. 2013;48:651\u20136. https:\/\/doi.org\/10.1038\/bmt.2012.204.","journal-title":"Bone Marrow Transpl"},{"key":"2734_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40262-020-00947-2","volume":"60","author":"R Lawson","year":"2021","unstructured":"Lawson R, Staatz CE, Fraser CJ, Hennig S. Review of the pharmacokinetics and pharmacodynamics of intravenous busulfan in paediatric patients. Clin Pharmacokinet. 2021;60:17\u201351. https:\/\/doi.org\/10.1007\/s40262-020-00947-2.","journal-title":"Clin Pharmacokinet"},{"key":"2734_CR24","doi-asserted-by":"publisher","first-page":"1007.e1","DOI":"10.1016\/j.jtct.2024.07.015","volume":"30","author":"T Bogn\u00e0r","year":"2024","unstructured":"Bogn\u00e0r T, Bartelink IH, van der Elst KCM, Kingma JS, Smeijsters EH, Lindemans CA, et al. Busulfan exposure target attainment in adults undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiple day therapeutic drug monitoring regimen. Transplant Cell Ther. 2024;30:1007.e1\u20131007.e10. https:\/\/doi.org\/10.1016\/j.jtct.2024.07.015.","journal-title":"Transplant Cell Ther"},{"key":"2734_CR25","doi-asserted-by":"publisher","first-page":"e526","DOI":"10.1016\/S2352-3026(16)30114-4","volume":"3","author":"IH Bartelink","year":"2016","unstructured":"Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, et al. Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis. Lancet Haematol. 2016;3:e526\u2013e536. https:\/\/doi.org\/10.1016\/S2352-3026(16)30114-4.","journal-title":"Lancet Haematol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02734-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02734-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T16:39:16Z","timestamp":1768927156000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-025-02734-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2734"],"URL":"https:\/\/doi.org\/10.1038\/s41409-025-02734-8","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"10 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study was performed in accordance with the Declaration of Helsinki. Specific ethical approval was not required for this retrospective registry study. EBMT Centres obtained informed consent from all participants according to the local regulations applicable at the time of transplantation to report pseudonymized data to the EBMT.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}